It was shown that the high levels of ZNF385A, LAMP, CADM3, NAV3, and NLGN1 indicate the poor prognosis of CRC patients (Martinez-Romero et al., 2018; Chang et al., 2021; Chen et al., 2021; Yu et al., 2021; Li et al., 2022), and these results were in accordance with our findings. This evidence concerns the gene ZNF385A and colorectal carcinoma.